SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: Steve Fancy who wrote (4752)7/6/1998 12:19:00 PM
From: Intel Trader  Read Replies (2) | Respond to of 6136
 
Hi Steve. re today's selling, kind of hard to tell where AGPH will end up in the very near term.

My opinion is that we are short term oversold. Now, that doesn't mean that AGPH can't/won't go to 26 or below, but I doubt it will go below 26 (next support level; after that my guess is about 23/24).

Longs shouldn't be worried here, unless they are on margin and have a huge position, (which is reckless IMO).

FWIW, there are at least 25 market makers in this stock who buy/sell it all day long. Currently, for ex, LEGG is bidding 27 1/4, ask 27 7/8. MSCO bid 27 1/4 x 28 1/4. and so forth. This changes all day long, with MMs making their money from trading on the spread and from commissions. If a major MM wants to get their company and/or a major client/s out, they will sell the stock all day long, and vice versa.

I don't intend to provide a class on trading here, but manipulation, although it does happen at times in certain stocks, is a miniscule concern. For the most part, MMs go with the market flow, and AGPH isn't an exception that I'd be aware of.

I'm just the proverbial 'flea on the elephant's ass' trying to get a small piece of the action.

regards,

it




To: Steve Fancy who wrote (4752)7/6/1998 1:53:00 PM
From: Izzy  Read Replies (2) | Respond to of 6136
 
Steve (and others): Do the July 30 (3/8) and Aug 30 (1 1/2) calls look any good to you? I don't see any new "put" volume. I'm trying to figure out if it's cheaper to buy the stock outright or jump on the "calls"; that is, what's my best bet for ROI at this time? IMO, this stock has to be oversold. Altho' MS has lowered projected earnings (doesn't surprise me any; I had mentioned this possibility on at least 2 prior posts) but there has been no "downgrade" of the stock. IMO, even AGPH thinks that the price drop is an "over-reaction." Any ideas or suggestions out there for now? Thanks.